Cathepsin B (CatB) was also found to be decreased in a mouse model [228], and the evidence of its important role in reducing Aβ-peptide levels reinforced the interest in cathepsins role in AD [229]. This evidence concerns the gene TYRP1 and Alzheimer disease.